Komori
The Kiyo Bank (8370) · FactMitigated

Deterioration in Other Comprehensive Income and Decline in the Valuation Difference on Available-for-Sale Securities

First written in FY2019-Q3. 5 of 22 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2026-H1.

22entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019-Q3 – FY2021-Q1AdvancedFY2021-Q2 – FY2022-Q2OtherFY2022 – FY2024-Q1WorsenedFY2024-Q2 – FY2024-Q32019: 420192020: 320202021: 420212022: 320222023: 420232024: 220242025: 22025
Same theme, other companies
Changes in Net Assets, Valuation Differences, etc.A theme 68 companies write about · 33 as a headwind · 26 as a tailwind

The whole theme swung hardest in 2022: 10 of 55 companies on the "Worse" side.

8 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 68 companies compared. The sentences above are computed from all 68.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「Valuation difference on available-for-sale securities △ 23,038 △ 15,888」

    The negative valuation difference on available-for-sale securities narrowed from ¥23,038 million at the end of the previous fiscal year to ¥15,888 million.
  2. FY2025WorsenedAnnual report

    「The valuation difference on available-for-sale securities changed from a negative ¥13,406 million at the end of the previous consolidated fiscal year to a negative ¥23,038 million.」

    The negative valuation difference on available-for-sale securities widened, deteriorating net assets in terms of valuation differences.
  3. FY2025-H1Widening Negative Valuation Difference on Available-for-Sale SecuritiesAnnual report

    「Valuation difference on available-for-sale securities　△13,406　△14,395」

    The negative valuation difference on available-for-sale securities widened from ¥13,406 million at the end of the previous fiscal year to ¥14,395 million.
  4. FY2024-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ 11,554 △ 15,127」

    The negative valuation difference on available-for-sale securities widened from ¥11,554 million at the end of the previous fiscal year to ¥15,127 million.
  5. FY2024-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities △ 11,554 △ 19,435」

    The negative valuation difference on available-for-sale securities widened from ¥11,554 million to ¥19,435 million.
  6. FY2024-Q1Narrowing of the negative valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities △ 11,554 △ 10,714」

    The negative valuation difference on available-for-sale securities narrowed from ¥11,554 million to ¥10,714 million. Quarterly comprehensive income also improved from a negative ¥10,016 million in the same period of the previous year to ¥3,883 million.
  7. FY2023Unrealized Gains or Losses on Other Securities Turning NegativeAnnual report

    「Valuation difference on available-for-sale securities 1,787 △ 11,554」

    The valuation difference on available-for-sale securities changed from a positive ¥1,787 million to a negative ¥11,554 million, while comprehensive income also changed from ¥1,681 million to a loss of ¥13,644 million.
  8. FY2023-Q3Widening Negative Valuation Difference on Available-for-Sale SecuritiesAnnual report

    「Valuation difference on available-for-sale securities 1,787 △ 27,748 Quarterly comprehensive income 14,725 △ 16,588」

    The valuation difference on available-for-sale securities changed from a positive ¥1,787 million at the end of the previous fiscal year to a negative ¥27,748 million, while quarterly comprehensive income also changed from ¥14,725 million to a loss of ¥16,588 million.
  9. FY2023-Q2Valuation difference on available-for-sale securities turned negative and widenedAnnual report

    「Valuation difference on available-for-sale securities 1,787 △ 20,109」

    The valuation difference on available-for-sale securities changed from a positive ¥1,787 million at the end of the previous fiscal year to a negative ¥20,109 million, while interim comprehensive income also amounted to a loss of ¥13,021 million.
  10. FY2023-Q1Unrealized Gains or Losses on Other Securities Turning NegativeAnnual report

    「Valuation difference on available-for-sale securities 1,787 △ 12,948 Quarterly comprehensive income 6,314 △ 10,016」

    The valuation difference on available-for-sale securities changed from a positive ¥1,787 million to a negative ¥12,948 million, while quarterly comprehensive income also changed from ¥6,314 million to a loss of ¥10,016 million.
  11. FY2022Sharp decline in valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 14,848 1,787」

    The valuation difference on available-for-sale securities fell sharply from ¥14,848 million at the end of the previous fiscal year to ¥1,787 million, while comprehensive income also decreased from ¥29,659 million to ¥1,681 million.
  12. FY2022-Q2AdvancedAnnual report

    「Valuation difference on available-for-sale securities 14,848 18,713」

    The valuation difference on available-for-sale securities increased from ¥14,848 million at the end of the previous fiscal year to ¥18,713 million, indicating further recovery in valuation differences.
  13. FY2022-Q1AdvancedAnnual report

    「Valuation difference on available-for-sale securities 14,848 16,036」

    The valuation difference on available-for-sale securities increased from ¥14,848 million at the end of the previous consolidated fiscal year to ¥16,036 million, indicating further recovery in valuation differences.
  14. FY2021AdvancedAnnual report

    「Valuation difference on available-for-sale securities　6,299　14,848」

    The valuation difference on available-for-sale securities increased from ¥6,299 million at the end of the previous fiscal year to ¥14,848 million, indicating further recovery in valuation differences.
  15. FY2021-Q3AdvancedAnnual report

    「Valuation difference on available-for-sale securities 6,299 14,730」

    The valuation difference on available-for-sale securities increased from ¥6,299 million at the end of the previous consolidated fiscal year to ¥14,730 million, indicating further recovery in valuation differences.
  16. FY2021-Q2AdvancedAnnual report

    「Valuation difference on available-for-sale securities 6,299 12,970」

    The valuation difference on available-for-sale securities increased from ¥6,299 million at the end of the previous fiscal year to ¥12,970 million, indicating further recovery in valuation differences.
  17. FY2021-Q1Recovery in valuation differences on other securitiesAnnual report

    「Valuation difference on available-for-sale securities 6,299 12,187」

    The valuation difference on available-for-sale securities increased from ¥6,299 million at the end of the previous consolidated fiscal year to ¥12,187 million, recovering from the declining trend seen through the most recent period.
  18. FY2020-Q3Continued Decline in Valuation Difference on Other SecuritiesAnnual report

    「Valuation differences on other securities 26,830 22,996」

    Valuation differences on other securities declined from ¥26.830 billion at the end of the previous fiscal year to ¥22.996 billion.
  19. FY2020-Q2Continued Decline in Valuation Difference on Other SecuritiesAnnual report

    「Valuation differences on other securities 26,830 23,477」

    Valuation differences on other securities declined from ¥26.830 billion at the end of the previous fiscal year to ¥23.477 billion, and the decline in valuation differences continued.
  20. FY2020-Q1Continued Decline in Valuation Difference on Other SecuritiesAnnual report

    「Valuation differences on other securities 26,830 21,684」

    Valuation differences on other securities declined from ¥26.830 billion at the end of the previous fiscal year to ¥21.684 billion, and the decline in valuation differences continued.
  21. FY2019Continued Decline in Valuation Difference on Other SecuritiesAnnual report

    「Valuation differences on other securities　29,300　26,830」

    Valuation differences on other securities declined from ¥29.300 billion to ¥26.830 billion, confirming a deterioration in valuation differences for the full fiscal year as well.
  22. FY2019-Q3First statedAnnual report

    「Quarterly comprehensive income　16,708　△2,552 Valuation differences on other securities　6,843　△10,871」

    Cumulative quarterly comprehensive income through the third quarter changed from ¥16.708 billion in the same period of the previous year to a loss of ¥2.552 billion, while valuation differences on other securities also moved from positive to negative.
Moved together

"Strengthening lending and earnings through relationship-banking-based sales" moved the same way as this thread, in the same document, in 6 of its 22 moves.

666555★123456
  1. ★This thread
  2. 1Strengthening lending and earnings through relationship-banking-based sales6×
  3. 2Growth in Outstanding Loans and Deposits6×
  4. 3Early achievement of ¥4 trillion in deposits6×
  5. 4Increase in net fees and commissions5×
  6. 5Risk of Decline in Capital Adequacy Ratio5×
  7. 6Risks Related to Changes in Accounting Standards, Deferred Tax Assets, and Retirement Benefits5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for The Kiyo Bank yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Deterioration in Other Comprehensive Income and Decline in the Valuation Difference on Available-for-Sale Securities | The Kiyo Bank,Ltd. (8370) | Komori